Inventor · disambiguated record
Vijay Kumar Nyavanandi
Also filed as: NYAVANANDI VIJAY KUMAR
6 granted patents·4 pending applications·10 citations·filing 2014–2020
75Inventor score
Top patents by PatentIndex Score
10 records- 0185US9796683B2Tetrasubstituted alkene compounds and their useEISAI R&D MAN CO LTD·Filed 2016·Granted Oct 24, 2017·6 cites·32 claims
- 0280US9499495B2Quinazolines and azaquinazolines as dual inhibitors of RAS/RAF/MEK/ERK and PI3K/AKT/PTEN/mTOR pathwaysASANA BIOSCIENCES LLC·Filed 2014·Granted Nov 22, 2016·4 cites·43 claims
- 0372US2021113578A1Quinazolines and azaquinazolines as dual inhibitors of ras/raf/mek/erk and pi3k/akt/pten/mtor pathwaysASANA BIOSCIENCES LLC·Filed 2020·Application pending·0 cites
- 0470US10912779B2Quinazolines and azaquinazolines as dual inhibitors of RAS/RAF/MEK/ERK and PI3K/AKT/PTEN/mTOR pathwaysASANA BIOSCIENCES LLC·Filed 2019·Granted Feb 9, 2021·0 cites·23 claims
- 0558US10226468B2Quinazolines and azaquinazolines as dual inhibitors of RAS/RAF/MEK/ERK and PI3K/AKT/PTEN/mTOR pathwaysASANA BIOSCIENCES LLC·Filed 2017·Granted Mar 12, 2019·0 cites·35 claims
- 0658US9757382B2Quinazolines and azaquinazolines as dual inhibitors of RAS/RAF/MEK/ERK and PI3K/AKT/PTEN/mTOR pathwaysASANA BIOSCIENCES LLC·Filed 2016·Granted Sep 12, 2017·0 cites·25 claims
- 0750US2018141913A1Tetrasubstituted alkene compounds and their useEISAI R&D MAN CO LTD·Filed 2017·Application pending·0 cites
- 0850US2020255415A1Tetrasubstituted alkene compounds and their use for the treatment of breast cancerEISAI R&D MAN CO LTD·Filed 2017·Application pending·0 cites
- 0949US10851065B2Tetrasubstituted alkene compounds and their useEISAI R&D MAN CO LTD·Filed 2017·Granted Dec 1, 2020·0 cites·20 claims
- 1038US2019337921A1Tetrasubstituted alkene compounds and their useEISAI R&D MAN CO LTD·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Vijay Kumar Nyavanandi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →